Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles

The aim of this study is to evaluate PET-CT and EmII/3-10 serology as potential markers to assess the parasitocidal effect of benzimidazoles

* Trial with medicinal product

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alveolar Echinococcosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Zurich

Zurich, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with inoperable alveolar echinococcosis
With negative PET-CT
EmII/3-10 serology under long-term chemotherapy with benzimidazoles

Exclusion criteria

Positive PET-CT
Positive EmII-3-10 Serology
No compliance
Reduced life expectancy
Pregnancy

Treatment and study plan

Stop treatment

Other

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

Analysis of the Potentially Parasitocidal Effect of a Long Term Chemotherapy With Benzimidazoles in Patients With Inoperable Alveolar Echinococcosis Using PET-CT and EmII/3-10 Serology

Important dates

Study start: 2008
Primary completion: 2012
Study completion: 2012
First posted: Apr 14, 2008
Registry last updated: Oct 17, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed